Skip to main content
. 2016 Oct 27;2016:3746791. doi: 10.1155/2016/3746791

Table 2.

Macular GCIPL, pRNFL thicknesses, and ONH parameters.

No β-PPA eyes (control) Myopic β-PPA eyes (case) Difference (control-case) P value
mGCIPL (μm)
Average 81.07 ± 4.31 78.93 ± 4.18 2.15 ± 2.44 <0.001
Minimum 78.93 ± 4.72 73.85 ± 8.07 5.07 ± 8.95 0.007
Superotemporal 81.11 ± 5.18 78.33 ± 5.10 2.78 ± 3.94 0.001
Superior 82.07 ± 4.90 79.63 ± 5.23 2.44 ± 3.33 0.001
Superonasal 83.07 ± 5.36 80.93 ± 6.29 2.14 ± 5.34 0.047
Inferonasal 80.70 ± 4.56 79.30 ± 5.25 1.41 ± 4.82 0.141
Inferior 78.04 ± 4.89 75.89 ± 6.27 2.15 ± 5.34 0.038
Inferotemporal 82.33 ± 4.09 80.07 ± 5.01 2.26 ± 4.18 0.009
pRNFL (μm)
Average 93.56 ± 8.51 91.44 ± 9.23 2.11 ± 4.42 0.020
Superior 117.70 ± 16.97 112.44 ± 20.83 5.26 ± 15.90 0.097
Temporal 74.33 ± 15.03 72.52 ± 13.55 1.81 ± 14.54 0.522
Inferior 118.93 ± 17.93 116.30 ± 15.16 2.62 ± 10.92 0.222
Nasal 64.07 ± 10.64 62.41 ± 9.78 1.67 ± 7.11 0.234
Clock hours R/L
12/12 111.71 ± 27.19 105.63 ± 28.13 6.07 ± 20.92 0.130
1/11 109.85 ± 17.15 104.74 ± 21.54 5.11 ± 17.70 0.146
2/10 88.30 ± 17.20 84.63 ± 15.68 3.67 ± 17.73 0.293
3/9 55.00 ± 11.83 53.48 ± 11.14 1.52 ± 12.40 0.771
4/8 60.59 ± 8.71 60.37 ± 7.16 0.22 ± 7.56 0.880
5/7 92.33 ± 17.97 90.00 ± 16.11 2.33 ± 12.64 0.346
6/6 123.19 ± 26.93 115.81 ± 26.11 7.37 ± 16.39 0.007
7/5 146.00 ± 20.74 143.81 ± 17.91 2.19 ± 13.91 0.422
8/4 79.37 ± 10.66 79.15 ± 13.11 0.22 ± 10.86 0.916
9/3 55.37 ± 10.83 54.26 ± 10.48 1.11 ± 10.24 0.511
10/2 77.00 ± 10.88 78.44 ± 17.08 −1.44 ± 17.19 0.666
11/1 131.00 ± 15.36 132.19 ± 15.34 −1.19 ± 13.30 0.210
ONH parameters
Rim area (mm3) 1.23 ± 0.17 1.20 ± 0.28 0.03 ± 0.21 0.416
Disc area (mm3) 1.74 ± 0.28 1.73 ± 0.31 0.01 ± 0.19 0.739
Average CDR 0.50 ± 0.13 0.50 ± 0.12 0.00 ± 0.08 0.829
Vertical CDR 0.46 ± 0.13 0.47 ± 0.12 −0.01 ± 0.08 0.611
Cup volume (mm3) 0.15 ± 0.12 0.15 ± 0.12 0.00 ± 0.09 0.983

mGCIPL, macular ganglion cell-inner plexiform layer; pRNFL, peripapillary retinal nerve fiber layer; ONH, optic nerve head; R, right; L, left; CDR, cup-to-disc ratio; β-PPA, β-zone parapapillary atrophy.